Myovant Sciences Ltd (MYOV)
BMG637AM1024 - Common Stock
| TTM (2022-12-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | 2020 (2020-3-31) | 2019 (2019-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -183.77M | -205.98M | -255.10M | -289.00M | -273.60M | |||
| Depreciation Amortization | 1.33M | 1.38M | 2.50M | 1.80M | 400.00K | |||
| Income Taxes - Deferred | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Change In Working Capital | -131.51M | -107.00M | 584.60M | 17.90M | 27.00M | |||
| Interest Paid | N/A | N/A | 0.00 | 13.00M | 3.90M | |||
| Taxes Paid | N/A | 3.54M | 500.00K | 0.00 | 0.00 | |||
| Other non cash items | 44.09M | 43.05M | 38.70M | 48.20M | 22.00M | |||
| OPERATING CASH FLOW | -269.87M | -268.56M | 370.60M | -221.20M | -224.10M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -865.00K | -974.00K | -1.80M | -1.10M | -1.20M | |||
| Other Investing Activity | 46.17M | -17.05M | -7.40M | -2.80M | N/A | |||
| INVESTING CASH FLOW | 45.31M | -18.02M | -9.20M | -3.90M | -1.20M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | 245.00M | 8.30M | N/A | |||
| Stock Issued/Repurchased | 13.48M | 24.63M | 6.70M | 137.90M | 220.20M | |||
| Other Financing Activity | N/A | 1.28M | -13.70M | -300.00K | 53.70M | |||
| FINANCING CASH FLOW | 13.48M | 25.91M | 238.00M | 145.90M | 273.90M | |||
| CHANGE IN CASH | -211.08M | -260.68M | 599.40M | -79.20M | 48.60M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -269.87M | -268.56M | 370.60M | -221.20M | -224.10M | |||
| Capital Expenditure | -865.00K | -974.00K | -1.80M | -1.10M | -1.20M | |||
| FREE CASH FLOW | -270.73M | -269.53M | 368.80M | -222.30M | -225.30M | |||
All data in USD